Ten-year trajectory of potentially inappropriate medications in very old women: Importance of cognitive status

Journal of the American Geriatrics Society

Volumn 61, Issue 2, 2013, Pages 258-263

  Koyama, Alain ^a,b   Steinman, Michael ^b,c   Ensrud, Kristine ^d,e   Hillier, Teresa A ^f   Yaffe, Kristine ^b,c,g  

^a NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f CENTER FOR HEALTH RESEARCH   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anticholinergic; cognitive function; dementia; potentially inappropriate medication

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; SPASMOLYTIC AGENT;

AGED; ARTICLE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DRUG UTILIZATION; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICATION ERROR; MILD COGNITIVE IMPAIRMENT; POTENTIALLY INAPPROPRIATE MEDICATION; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DEMENTIA; DRUG UTILIZATION; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; MEDICATION ERRORS; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84873988337     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12093     Document Type: Article

References (30)

1. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-2724.
2. Corsonello A, Pedone C, Incalzi RA,. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem 2010; 17: 571-584.
3. Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72-83.
4. Gallagher PF, O'Connor MN, O'Mahony D,. Prevention of potentially inappropriate prescribing for elderly patients: A randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011; 89: 845-854.
5. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996; 100: 428-437.
6. Egger SS, Bachmann A, Hubmann N, et al. Prevalence of potentially inappropriate medication use in elderly patients: Comparison between general medical and geriatric wards. Drugs Aging 2006; 23: 823-837.
7. Barton C, Sklenicka J, Sayegh P, et al. Contraindicated medication use among patients in a memory disorders clinic. Am J Geriatr Pharmacother 2008; 6: 147-152.
8. Campbell N, Boustani M, Limbil T, et al. The cognitive impact of anticholinergics: A clinical review. Clin Interv Aging 2009; 4: 225-233.
9. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women Study of Osteoporotic Fractures Research Group. N Engl J Med 1995; 332: 767-773.
10. Pahor M, Chrischilles EA, Guralnik JM, et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 1994; 10: 405-411.
11. Barker MJ, Greenwood KM, Jackson M, et al. Cognitive effects of long-term benzodiazepine use: A meta-analysis. CNS Drugs 2004; 18: 37-48.
12. Mort JR, Aparasu RR,. Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly. Arch Intern Med 2000; 160: 2825-2831.
13. Boustani M, Campbell N, Munger S, et al. Impact of anticholinergics on the aging brain: A review and practical application. Aging Health 2008; 4: 311-320.
14. Campbell NL, Boustani MA, Lane KA, et al. Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology 2010; 75: 152-159.
15. Yaffe K, Middleton LE, Lui LY, et al. Mild cognitive impairment, dementia, and their subtypes in oldest old women. Arch Neurol 2011; 68: 631-636.
16. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, DC: American Psychiatric Association, 1994.
17. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985-1992.
18. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-383.
19. Jyrkka J, Enlund H, Korhonen MJ, et al. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: Results of the Kuopio 75 + study: A cross-sectional analysis. Drugs Aging 2009; 26: 493-503.
20. Crowley K,. Sleep and sleep disorders in older adults. Neuropsychol Rev 2011; 21: 41-53.
21. Vink D, Aartsen MJ, Schoevers RA,. Risk factors for anxiety and depression in the elderly: A review. J Affect Disord 2008; 106: 29-44.
22. Defilippi JL, Crismon ML,. Drug interactions with cholinesterase inhibitors. Drugs Aging 2003; 20: 437-444.
23. Carnahan RM, Lund BC, Perry PJ, et al. The concurrent use of anticholinergics and cholinesterase inhibitors: Rare event or common practice?. J Am Geriatr Soc 2004; 52: 2082-2087.
24. Sink KM, Thomas J III, Xu H, et al. Dual use of bladder anticholinergics and cholinesterase inhibitors: Long-term functional and cognitive outcomes. J Am Geriatr Soc 2008; 56: 847-853.
25. Fox C, Richardson K, Maidment ID, et al. Anticholinergic medication use and cognitive impairment in the older population: The Medical Research Council Cognitive Function and Ageing Study. J Am Geriatr Soc 2011; 59: 1477-1483.
26. Verdoux H, Lagnaoui R, Begaud B,. Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychol Med 2005; 35: 307-315.
27. Johnell K, Weitoft GR, Fastbom J,. Sex differences in inappropriate drug use: A register-based study of over 600,000 older people. Ann Pharmacother 2009; 43: 1233-1238.
28. Aparasu RR, Mort JR,. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000; 34: 338-346.
29. Obermeyer CM, Schulein M, Hardon A, et al. Gender and medication use: An exploratory, multi-site study. Women Health 2004; 39: 57-73.
30. Artero S, Ancelin ML, Portet F, et al. Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry 2008; 79: 979-984.